Secretion of cardiac plasminogen activator during hypoxia-induced right ventricular hypertrophy

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 11, 1997, Pages 3105-3114

  Bansal, Devi D ^a   Klein, Robert M ^b   Hausmann, Elda H S ^b   MacGregor, Ronal R ^b  

^a PANJAB UNIVERSITY   (India)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertrophy; Hypoxia; Plasminogen activator

Indexed keywords

FIBRIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; HALF LIFE TIME; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; NONHUMAN; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; VASCULARIZATION;

EID: 0031281953     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0536     Document Type: Article

References (28)

1. ABRAHAM WT, RAYNOLDS MV, GOTTSCHALL B, BADESCH DB, WYNNE KM, GROVES BM, LOWES BD, BRISTOW MR, PERRYMAN MB, VOELKEL NF, 1995. Importance of angiotensin converting enzyme in pulmonary hypertension. Cardiol 86 (Suppl. 1): 9-15.
2. BRILLA CG, PICK R, TAN LB, JANICKI JS, WEBER KT, 1990. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67: 1355-1364.
3. BULENS F, THOMPSON AE, STASSEN JM, MOREAU H, DECLRCK PJ, NELLES L, COLLEN D, 1992. Induction of tPA synthesis with intravenous bolus injection of vitamin A palmitate in vitamin A-deficient rats. Fibrinolysis 6: 243-249.
4. CAMPBELL EE, SHITMAN MA, LEWIS JG, PASQUA JJ, PIZZO SV, 1982. A colorimetric assay for releasable plasminogen activator. Clin Chem 28: 1125-1128.
5. CARROLL SM, NIMMO LE, KNOEPFLER PS, WHITE FC, BLOOR CM, 1995. Gene expression in a swine model of right ventricular hypertrophy: intercellular adhesion molecule, vascular endothelial growth factor and plasminogen activators are upregulated during pressure overload. Mol Cell Cardiol 27: 1427-1441.
6. CHOMCZYNSKI P, SACCHI N, 1987. Single step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
7. DANO K, ANDREASEN PA, GRONDAHL-HANSEN J, KRISTENSEN P, NIELSEN, 1985. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 139-266.
8. HAUSMANN EHS, HAO S-Y, PACE JL, PARMELY MJ, 1994. Transforming growth factor 1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages. Infection Immunity 62: 3625-3632.
9. KLEIN RM, MACGILLIVRAY BK, MCKENZIE JC, 1995. Markers of cardiac hypertrophy. Ann NY Acad Sci 752: 210-217.
10. LEVIN EG, LOSKUTOFF DJ, 1982. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol 94: 631-636.
11. MATSUBARA F, SUEISHE K, ISHII Y, TANAKA K, 1985. Release of plasminogen activator from isolated perfused dog heart. Thromb Haemost 53: 126-129.
12. MCKENZIE JC, KLEIN RM, 1983. Protein synthesis in the rat pulmonary trunk during the early development of hypoxia-induced pulmonary hypertension. Blood Vessels 20: 283-294.
13. MCKENZIE JC, HUNG K-S, MATTIOLI L, KLEIN RM, 1984. Reduction in hypertension-induced protein synthesis in the rat pulmonary trunk after treatment with teprotide (SQ 20881) (41959). Proc Soc Exp Biol Med 177: 377-382.
14. MEYRICK B, REID L, 1978. The effect of continued hypoxia on rat pulmonary arterial circulation: an ultra-structural study. Lab Invest 38: 188-200.
15. 3H-thymidine by cells of the rat pulmonary arteries and alveolar wall. Am J Pathol 96: 51-70.
16. MELTON DA, KRIEG PA, REBEGELLIATI MR, MANIATIS T, KINN K, GREEN MR, 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing the bacteriophage SP6 pro-motor. Nud Acid Res 12: 7035-7056.
17. MORRELL NW, MORRIS KG, STENMARK KR, 1995. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 269 (Heart Circ Physiol 38): H1186-H1194.
18. NILSSON IM, LJUNGNER, TENGBORN L, 1985. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Brit Med J 290: 1453-1456.
19. QUAX HA, VAN DEN HOOGEN M, VERHEIJEN JH, PADRO T, ZEHAB R, GELEHRTER TD, VAN BERKEL TJC, KUIPER J, EMEIS JJ, 1990. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 265: 15560-15563.
20. RIDKER PM, VAUGHAN DE, STAMPFER MJ, MANSON JE, HENNEKENS CH, 1993. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. The Lancet 341: 1165-1168.
21. RIDKER PM, HENNEKENS CH, STAMPFER MJ, MANSON JE, VAUGHAN, 1994. Prospective study of endogenous tissue plasminogen activator and risk of stroke. The Lancet 343: 940-943.
22. SCHNEIDERMAN J, EGUCHI Y, ADAR R, SAWDEY M, 1994. Modulation of the fibrinolytic system by major peripheral ischemia. J Vasc Surg 19: 516-524.
23. TRANQUILLE N, EMEIS JJ, 1989. Protein synthesis inhibition by cycloheximide does not affect the acute release of tissue-type plasmixogen activator b. Thromb Haemostasis 61: 442-447.
24. VALEN G, ERIKSSON E, RISBERG B, VAAGE J, 1993. Reactive oxygen intermediates and ischemia-reperfusion injury release tissue plasminogen activator from isolated rat hearts. Thromb Res 71: 113-121.
25. VAN MOURIK JA, LAWRENCE DA, LOSKUTOFF DJ, 1984. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J Biol Chem 259: 14914-14921.
26. VAN WERSH JWJ, ROMPELBERG-LAHAYE J, LUSTERMANS FATH, 1991. Plasma concentration of coagulation and fibrinolysis factors and platelet function in hypertension. Eur J Clin Chem Clin Biochem 29: 375-379.
27. VASSALLI J-D, BELIN D, 1987. Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 214: 187-191.
28. WHITE FC, NIMMO BA, NAKATANI Y, BLOOR CM, 1992. Compensatory angiogenesis during progressive right ventricular hypertrophy. Am J Cardiovasc Pathol 4: 51-68.